Sensitivity of SARS/MERS CoV to Interferons and Other Drugs Based on Achievable Serum Concentrations in Humans

Publisher： Bentham Science Publishers

E-ISSN： 2212-3989|14|1|37-43

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.14, Iss.1, 2014-03, pp. : 37-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A New Nucleotide-composition Based Fingerprint of SARS-CoV with Visualization Analysis

By  

Medicinal Chemistry, Vol. 1, Iss. 1, 2005-01 ,pp. : 39-47

Bentham Science Publishers

Access to resources Recommend Favorite

Bioinformatics Research on the SARS Coronavirus (SARS_CoV) in China

By  

Current Pharmaceutical Design, Vol. 12, Iss. 35, 2006-12 ,pp. : 4565-4572

Bentham Science Publishers

Access to resources Recommend Favorite

Antiviral Drug Discovery Against SARS-CoV

By  

Current Medicinal Chemistry, Vol. 13, Iss. 17, 2006-07 ,pp. : 2003-2020

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Potent Anti-SARS-CoV MPro Inhibitors

By  

Current Computer - Aided Drug Design, Vol. 3, Iss. 3, 2007-09 ,pp. : 191-200

Bentham Science Publishers

Access to resources Recommend Favorite

Unraveling the complexities of the interferon response during SARS-CoV infection

By de Lang Anna   Baas Tracey   Smits Saskia L   Katze Michael G   Osterhaus Albert DME   Haagmans Bart L  

Future Virology, Vol. 4, Iss. 1, 2009-01 ,pp. : 71-78

Future Medicine

Access to resources Recommend Favorite